Pharmacokinetics interaction study of MK-5172 and Efavirenz

Trial Profile

Pharmacokinetics interaction study of MK-5172 and Efavirenz

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Dec 2015

At a glance

  • Drugs Efavirenz (Primary) ; Grazoprevir (Primary)
  • Indications Hepatitis C; HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top